Cargando…

Ketosis-Prone Type 2 Diabetes in a Veteran Population

Detalles Bibliográficos
Autores principales:	Goodstein, Gelsey, Milanesi, Anna, Weinreb, Jane E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Online Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392899/ https://www.ncbi.nlm.nih.gov/pubmed/24652736 http://dx.doi.org/10.2337/dc13-2824

Ejemplares similares

Ketosis-Onset Diabetes and Ketosis-Prone Diabetes: Same or Not?
por: Liu, Beiyan, et al.
Publicado: (2013)

Ketosis-Prone Type 2 Diabetes: A Case Series
por: Sjöholm, Åke
Publicado: (2019)

Ketosis-Prone Type 2 Diabetes Mellitus: An Unusual Presentation
por: Makahleh, Lana, et al.
Publicado: (2022)

Bodyweight threshold for sudden onset of ketosis might exist in ketosis‐prone type 2 diabetes patients
por: Satomura, Atsushi, et al.
Publicado: (2019)

Ketosis prone diabetes presenting as fulminant type 1 diabetes
por: krompa, Katerina, et al.
Publicado: (2018)

Pathogenesis of A(−)β(+) Ketosis-Prone Diabetes
por: Patel, Sanjeet G., et al.
Publicado: (2013)

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too
por: Lefèbvre, Pierre
Publicado: (2013)

Ketosis-Prone Diabetes (KPD): case report
por: Giorgi, Rafael Buck, et al.
Publicado: (2015)

Assessment of Emotional Struggles in Type 2 Diabetes: Patient Perspectives
por: Beverly, Elizabeth A., et al.
Publicado: (2012)

Glucose-6-Phosphate Dehydrogenase Deficiency and Type 2 Diabetes
por: Heymann, Anthony D., et al.
Publicado: (2012)

High Atherogenic Risk in Ketosis-Prone Type 2 Diabetic Individuals with Ketosis Episodes: A Cross-Sectional Study
por: He, Xiaoyu, et al.
Publicado: (2023)

Severe Thrombocytopenia Due to Repaglinide in a Patient With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2013)

Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China
por: Zhao, Wenjing, et al.
Publicado: (2013)

Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes
por: Umpierrez, Guillermo E., et al.
Publicado: (2010)

Bariatric Surgery Does Not Exacerbate and May Be Beneficial for the Microvascular Complications of Type 2 Diabetes
por: Miras, Alexander D., et al.
Publicado: (2012)

Anti-Pituitary Antibodies and Hypogonadotropic Hypogonadism in Type 2 Diabetes: In Search of a Role
por: Bellastella, Giuseppe, et al.
Publicado: (2013)

Localized Amyloidosis at the Site of Repeated Insulin Injection in a Patient With Type 2 Diabetes
por: Okamura, Shintaro, et al.
Publicado: (2013)

Type 1 Diabetes Caused by Interferon α-2α in Polycythemia Vera Therapy
por: Wang, Xian-Ling, et al.
Publicado: (2010)

No Relation Between Cystic Fibrosis–Related Diabetes and Type 1 Diabetes Autoimmunity
por: Gottlieb, Peter A., et al.
Publicado: (2012)

Dietary Quality in Adolescents With Type 1 Diabetes
por: Bansal, Nidhi, et al.
Publicado: (2013)

Effects of Qigong on Glucose Control in Type 2 Diabetes: A randomized controlled pilot study
por: Sun, Guan-Cheng, et al.
Publicado: (2010)

Low Prevalence of Diabetic Retinopathy in a Chinese Population
por: Yuan, Ming-Xia, et al.
Publicado: (2012)

Risk Factors of Ketosis in Obese Ketosis-Prone Diabetic Patients: A Case-Control Study
por: Shi, Li, et al.
Publicado: (2020)

Global Reality of Type 1 Diabetes Care in 2013
por: Beran, David, et al.
Publicado: (2013)

Glycogenic Hepatopathy in Type 1 Diabetes: An Underrecognized Condition
por: Imtiaz, Komal Eram, et al.
Publicado: (2013)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Cardiovascular Biomarkers, Cardiac Dysfunction, and Outcomes in Patients With Type 2 Diabetes: A Prospective, Multicenter Study
por: Masson, Serge, et al.
Publicado: (2013)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes
por: Waddankeri, Swaraj Shrikant, et al.
Publicado: (2021)

Pharmacokinetics of Insulin Aspart in Pump-Treated Subjects With Type 1 Diabetes: Reproducibility and Effect of Age, Weight, and Duration of Diabetes
por: Haidar, Ahmad, et al.
Publicado: (2013)

Computer and Internet Use of Urban African Americans With Type 2 Diabetes in Relation to Glycemic Control, Emergency Department Use, Diabetes-Related Knowledge, and Health Literacy
por: Samal, Lipika, et al.
Publicado: (2010)

“Mind the Gap” When Managing Ketoacidosis in Type 1 Diabetes
por: Lee, Paul, et al.
Publicado: (2008)

Quality of Diabetes Care in Italy: Information From a Large Population-Based Multiregional Observatory (ARNO Diabetes)
por: Bruno, Graziella, et al.
Publicado: (2012)

Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals
por: Ye, Shu, et al.
Publicado: (2021)

A Pediatric Case of Ketosis-Prone Type 2 Diabetes Requiring Insulin Therapy
por: Matsuura, Misa, et al.
Publicado: (2022)

Development and validation of a novel nomogram for prediction of ketosis-prone type 2 diabetes
por: Min, Rui, et al.
Publicado: (2023)

Ketosis-Prone Type 2 Diabetes (Flatbush Diabetes) in Remission: A Report of Two Cases
por: Ji, Beisi, et al.
Publicado: (2022)

The first series of cases of ketosis-prone type 2 diabetes (flatbush diabetes) in Brazilian adults
por: Ramaldes, Luana Aparecida de Lima, et al.
Publicado: (2021)

Association Between Serum Vitamin D Levels and Ketosis Episodes in Hospitalized Patients with Newly Diagnosed Ketosis-Prone Type 2 Diabetes
por: He, Xiaoyu, et al.
Publicado: (2022)

Improved Peripheral Perfusion During Endothelin-A Receptor Blockade in Patients With Type 2 Diabetes and Critical Limb Ischemia
por: Kalani, Majid, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gp149u706cnk94apvfrtdts0ij